Moderna Therapeutics
Chang Tian, Ph.D., is a Principal Engineer at Moderna since August 2020, specializing in lipid nanoparticle formulation and process development, leveraging fundamental science, advanced experimental techniques, and computational fluid dynamics (CFD) simulation. Prior roles include Senior Engineer I and Senior Engineer II in lipid nanoparticle process science. Chang Tian's earlier experience includes a research and development internship at Evonik, focusing on hot melt extrusion and spray drying of modified release dietary supplements. Educational credentials include a Ph.D. in Chemical Engineering from Princeton University and a B.S. in Chemical and Biomolecular Engineering from Rice University.
Moderna Therapeutics
125 followers
Moderna Therapeutics is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA.